Workflow
Patent Infringement
icon
Search documents
Apple Asks Judge to Dismiss Fintiv's Racketeering Lawsuit Focused on Apple Pay
PYMNTS.com· 2025-10-28 21:59
Core Points - Apple has requested a judge to dismiss a racketeering lawsuit filed by Fintiv, which alleges that Apple stole technology to create Apple Pay and engaged in racketeering by generating fees for credit card issuers [1][2] - Fintiv claims that Apple posed as a potential partner to gain access to its mobile wallet technology, leading to the alleged theft of trade secrets and technology [4][5] Legal Proceedings - Apple argues that Fintiv delayed pursuing most of its claims and failed to demonstrate a pattern of racketeering [2] - If the case is not dismissed, Apple has requested that it be transferred to a Texas judge who is already familiar with a related patent case involving Fintiv [3] - Fintiv's previous patent case against Apple was dismissed on August 4, and Fintiv is currently appealing that decision [3][6] Background Information - Fintiv's predecessor, Mozido, established a phone-based payment remittance business with Western Union and RadioShack in 2008 [4] - The lawsuit filed by Fintiv in August accuses Apple of racketeering and theft of trade secrets related to the technology powering Apple Pay [4] - The complaint alleges that Apple engineers attended technical sessions under nondisclosure agreements and subsequently hired key personnel from Fintiv's predecessor, incorporating their technology into Apple Pay's launch in 2014 [5]
Court of Appeals for Federal Circuit Grants ParkerVision's Motion to Expedite Appeal in Qualcomm Patent Case
Accessnewswire· 2025-10-23 11:30
Core Points - ParkerVision, Inc. has received approval from the United States Court of Appeals for the Federal Circuit to expedite its appeal in the patent-infringement case against Qualcomm Incorporated and Qualcomm Atheros, Inc. [1] - The court has set specific deadlines for the submission of briefs: ParkerVision's opening brief is due by December 1, 2025, Qualcomm's response brief by January 16, 2026, and ParkerVision's reply brief by February 6, 2026 [1] - Oral arguments will be scheduled for the next available session after the completion of the briefing process [1]
Alpha Modus Files Patent Infringement Lawsuit Against Lowe's for Unauthorized Use of AI Retail Technology
Globenewswire· 2025-10-14 13:49
Core Viewpoint - Alpha Modus, Corp. has filed a patent infringement lawsuit against Lowe's Companies, Inc. and Lowe's Home Centers, LLC, asserting six U.S. patents related to AI-driven retail technologies [1][3]. Patent Infringement Details - The lawsuit claims infringement of six patents covering technologies for real-time inventory management, customer assistance, personalized in-store advertising, dynamic store layout optimization, and behavioral data-driven retail engagement [3][5]. - The accused Lowe's systems include Dwell heat-mapping platform, Axis/Genetec camera network, Store Digital Twin, One Roof Media Network, Mylow Companion AI application, and Innovation Labs initiatives, which utilize real-time behavioral and visual analytics [4][6]. Technology Overview - The asserted patents protect methods for: - Using image recognition and behavioral data for dynamic inventory and pricing management [5]. - Delivering real-time personalized promotions based on shopper sentiment [5]. - Generating optimized store layouts from traffic and dwell-time analytics [5]. - Integrating AI-driven personalization engines linking in-store behavior with digital marketing [6]. Company Background - Alpha Modus Holdings, Inc. develops and licenses patented AI technologies that enhance physical retail performance through behavioral analytics and real-time computer vision [7].
Netlist Files Legal Action Against Samsung in the U.S. International Trade Commission
Accessnewswire· 2025-09-30 12:00
Core Viewpoint - Netlist, Inc. has initiated legal proceedings against Samsung, Google, and Super Micro at the U.S. International Trade Commission (ITC) for patent infringement, seeking exclusion and cease and desist orders [1][2]. Group 1: Legal Action Details - The legal action involves six patents owned by Netlist, specifically U.S. Patent Nos. 12,737,366, 10,025,731, 10,268,608, 10,217,523, 9,824,035, and 12,308,087, which pertain to various memory products including DDR5 memory modules and high-bandwidth memory [2]. - The ITC is an independent agency that investigates unfair acts in import trade that violate U.S. intellectual property rights, with investigations typically progressing to trial within a year [3]. Group 2: Company Background - Netlist is recognized as a leading innovator in advanced memory and storage solutions, with a strong portfolio of patented technologies that are foundational to AI computing advancements [4].
Align Technology files ITC complaint against Angelalign over patent-infringing NASDAQ:ALGN
Seeking Alpha· 2025-09-23 21:52
Core Viewpoint - The article emphasizes the importance of enabling Javascript and cookies in browsers to ensure proper functionality and access to content [1] Group 1 - The article suggests that users may face access issues if they have an ad-blocker enabled [1] - It highlights the need to disable ad-blockers and refresh the page for a better experience [1]
Alpha Modus files patent infringement lawsuit against Mood Media
Yahoo Finance· 2025-09-23 13:20
Core Insights - Alpha Modus (AMOD) has filed a patent infringement lawsuit against Mood Media in the U.S. District Court for the Western District of Texas, claiming infringement of seven U.S. patents related to real-time shopper analytics and other technologies [1] - Mood Media operates in over 500,000 retail and hospitality locations across more than 140 countries, reaching approximately 165 million consumers daily [1] - The lawsuit seeks damages for past and ongoing infringement, as well as an injunction to prevent further use of Alpha Modus's patented technologies [1] Company Overview - Alpha Modus is asserting its intellectual property rights through a lawsuit against a major player in the experiential media industry, indicating a focus on protecting its innovations [1] - Mood Media's portfolio includes various technologies such as digital signage, AI-powered messaging platforms, and IoT sensors, highlighting its extensive capabilities in enhancing customer experiences [1] Legal Context - The lawsuit involves seven specific patents, which cover innovations in areas such as targeted advertising and inventory management, suggesting a significant technological overlap between the two companies [1] - The legal action reflects the competitive landscape in the retail technology sector, where companies are increasingly reliant on proprietary technologies to differentiate their offerings [1]
Alpha Modus Sues Mood Media in Major Patent Fight Over AI Retail Tech Reaching 165 Million Consumers Daily
Globenewswire· 2025-09-22 13:00
Core Viewpoint - Alpha Modus Corp. has filed a patent infringement lawsuit against Mood Media, asserting that Mood Media has unlawfully utilized its patented technologies in retail engagement [1][4]. Group 1: Patent Infringement Details - The lawsuit claims infringement of seven U.S. patents related to innovations in real-time shopper analytics, targeted advertising, inventory management, planogram optimization, and personalized in-store engagement [2]. - The patents involved are Nos. 10,360,571; 10,853,825; 12,039,550; 11,042,890; 11,301,880; 11,049,120; and 12,026,731 [2]. Group 2: Mood Media Overview - Mood Media is a major experiential media provider, operating in over 500,000 retail and hospitality locations across more than 140 countries, reaching approximately 165 million consumers daily [3]. - Its offerings include digital signage, smart shelving, AI-powered messaging platforms, IoT sensors, and scent marketing [3]. Group 3: Legal Actions and Objectives - The lawsuit seeks damages for past and ongoing infringement, an injunction to prevent further use of Alpha Modus's patented technologies, and other legal remedies [4]. - Alpha Modus aims to enforce its patent portfolio within the retail and advertising sectors to ensure proper licensing or partnership for its AI technologies [4]. Group 4: Company Background - Alpha Modus (NASDAQ: AMOD) specializes in developing and licensing AI-driven retail technologies aimed at enhancing the in-store experience [5]. - The company's patent portfolio includes technologies for real-time consumer behavior analytics, AI-powered planogramming, personalized digital engagement, dynamic pricing, and intelligent inventory management [5].
Alpha Modus Files Patent Infringement Lawsuit Against MNTN, Inc. in the Western District of Texas
Globenewswire· 2025-09-12 12:00
Core Viewpoint - Alpha Modus Holdings, Inc. has filed a patent infringement lawsuit against MNTN, Inc. to protect its intellectual property and shareholder interests while also expressing a willingness to collaborate with potential adversaries [1][5][6]. Patent Infringement Details - The lawsuit asserts infringement of three key patents that are central to Alpha Modus's technology, which aims to enhance consumer engagement at the point of sale [3][5]. - The specific patents involved include: - U.S. Patent No. 10,360,571: Methods for monitoring and analyzing consumer behavior in real time [5]. - U.S. Patent No. 11,042,890: Systems for enhancing in-store customer assistance using advanced monitoring and sentiment analysis [5]. - U.S. Patent No. 12,026,731: Personalized marketing and advertising linked to real-time consumer interactions and location tracking [5]. Industry Context - Alpha Modus has previously filed similar patent infringement actions against major retailers and advertising networks, highlighting its role as a pioneer in protecting and monetizing technologies within the $60+ billion retail media and self-service kiosk markets [7]. - The lawsuit against MNTN seeks damages, injunctive relief, and validation of Alpha Modus's patents [8]. Company Overview - Alpha Modus Holdings, Inc. is a publicly traded company focused on AI-driven retail and fintech solutions, leveraging a growing patent portfolio to redefine consumer engagement [9].
Neonode Announces Anticipated Financial Proceeds from Patent Lawsuit Settlement
Prnewswire· 2025-09-03 20:47
Core Viewpoint - Neonode Inc. anticipates receiving net proceeds of approximately US$15 million to US$20 million from a settlement related to a patent infringement lawsuit involving its subsidiary Aequitas Sub and Samsung Electronics [2][5]. Group 1: Settlement Details - The lawsuit was filed by Aequitas Sub against Samsung on June 8, 2020, alleging patent infringement, and was dismissed on September 2, 2025, following a settlement [5]. - Neonode is entitled to 50 percent of any net proceeds from the settlement based on the Assignment Agreement with Aequitas Technologies LLC [1][4]. - The expected net proceeds will be calculated after deducting brokerage fees, legal fees, taxes, and other expenses [2][4]. Group 2: Financial Implications - The anticipated net proceeds of US$15 million to US$20 million will be subject to further evaluation regarding tax implications and other financial considerations [2][3]. - As of September 3, 2025, the Board of Directors has not made a decision on the use of the proceeds from the settlement [3]. Group 3: Background Information - In 2019, Neonode assigned a portfolio of patents to Aequitas, which allows the company to share in potential net proceeds from licensing and monetization efforts by Aequitas [4]. - A separate patent infringement case against Apple Inc. by Aequitas Sub remains pending in California [6].
Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation
Prnewswire· 2025-04-24 12:30
Core Viewpoint - Halozyme Therapeutics has filed a patent infringement lawsuit against Merck, alleging that Merck's development of subcutaneous Keytruda infringes on Halozyme's patented MDASE technology [1][2][5] Company Overview - Halozyme is a biotechnology company that specializes in subcutaneous drug delivery using human hyaluronidase, with a focus on improving patient outcomes through innovative drug delivery solutions [1][6] - The company has developed the ENHANZE® drug delivery technology, which facilitates rapid subcutaneous delivery of therapeutic drugs, and has partnered with major pharmaceutical companies to enhance patient experiences [6][8] Patent Infringement Details - Halozyme claims that Merck has used its MDASE technology without permission to develop subcutaneous Keytruda, which has completed phase 3 clinical testing and is expected to launch in 2025 [2][3] - The lawsuit seeks damages and injunctive relief to prevent Merck from launching SC Keytruda, as Halozyme believes Merck is aware of the infringement [5][6] Research and Development - Halozyme's patents stem from extensive research involving nearly 7,000 modifications to human hyaluronidases, which enable rapid subcutaneous administration of therapeutic drugs [4] - The company's innovations in hyaluronidases represent significant advancements in the field, providing a roadmap for enhancing drug delivery mechanisms [4] Legal Context - Halozyme's Chief Legal Officer stated that Merck's actions indicate a clear infringement of Halozyme's patents, and the lawsuit aims to enforce these rights without affecting Halozyme's existing ENHANZE® licensing program [5][6]